Products

What will AGI do for Azasetron hydrochloride?

This classification denotes a 5-ht3 receptor antagonist with the molecular formula C17H20ClN3O3.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2BSS7XL60S, chemically known as 2h-1,4-benzoxazine-8-carboxamide, n-1-azabicyclo(2.2.2)oct-3-yl-6-chloro-3,4-dihydro-4-methyl-3-oxo-, monohydrochloride but generally known as azasetron hydrochloride, which bears US NIH Compound Identifier 115000. European Medicines Agency schedules Azasetron hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00639MIG. Most nations schedule azasetron hydrochloride under HS 29349990 and SITC 51579. As of Q4 2014, AZASETRON HYDROCHLORIDE remains the US FDA Preferred Term for this commodity. Azasetron hydrochloride bears US NLM identifiers UMLS ID C2698288 and NCI Concept Code C77260. SMILES: Clc1cc(C(=O)NC2C3CCN(C2)CC3)c2OCC(=O)N(c2c1)C.Cl.